Bristol-Myers Squibb Co
XHAM:BRM
Bristol-Myers Squibb Co
XHAM:BRM
Price:
53.34
EUR
1.04%
Market Cap:
€118.4B
Relative Value
The Relative Value of one
BRM
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 53.34 EUR,
Bristol-Myers Squibb Co
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BRM Relative Value
HIDDEN
Multiples Across Competitors
BRM Competitors Multiples
Bristol-Myers Squibb Co Competitors
Bristol-Myers Squibb Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
XHAM:BRM
|
125.8B EUR | 2.6 | 17.5 | 7.3 | 9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.4B USD | 14.4 | 45.4 | 30.6 | 32.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.2B USD | 6.2 | 21.7 | 15 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.1B CHF | 4.6 | 29.9 | 12.6 | 14.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
243.9B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.8B GBP | 5.3 | 30.3 | 16.8 | 23.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.5 | 16 | 10 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.7 | 7.9 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.3 | 7.5 | 9.9 | |
| UK |
|
GSK plc
XETRA:GS71
|
99B EUR | 2.6 | 15.1 | 7.7 | 10.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
